WallStreetZenWallStreetZen

NASDAQ: NRIX
Nurix Therapeutics Inc Stock Ownership - Who owns Nurix Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Nurix Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Houte Hans VanChief Financial Officer2025-03-035,125$14.40
$73.79kSell
Houte Hans VanChief Financial Officer2025-03-03700$15.13
$10.59kSell
Christine RingChief Legal Officer2025-01-31223$1.86
$414.78Buy
Christine RingChief Legal Officer2025-01-315,537$1.86
$10.30kBuy
Christine RingChief Legal Officer2025-01-31100$20.48
$2.05kSell
Christine RingChief Legal Officer2025-01-315,660$19.95
$112.89kSell
Houte Hans VanChief Financial Officer2025-01-302,557$19.81
$50.65kSell
Christine RingChief Legal Officer2025-01-302,929$19.81
$58.01kSell
Gwenn HansenChief Scientific Officer2025-01-303,357$19.81
$66.49kSell
Gwenn HansenChief Scientific Officer2025-01-30333$20.33
$6.77kSell

1 of 7

NRIX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when NRIX insiders and whales buy or sell their stock.

NRIX Shareholders

What type of owners hold Nurix Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Fmr LLC13.95%10,634,231$108.89MInstitution
Blackrock Inc10.07%7,675,672$78.60MInstitution
Vanguard Group Inc5.70%4,345,266$44.50MInstitution
Redmile Group LLC5.50%4,192,627$42.93MInstitution
Baker Bros Advisors LP5.09%3,882,125$39.75MInstitution
Wellington Management Group LLP4.70%3,586,605$36.73MInstitution
Third Rock Ventures III LP4.60%3,509,348$35.94MInsider
Price T Rowe Associates Inc3.94%3,007,327$30.80MInstitution
Deep Track Capital LP3.94%3,000,000$30.72MInstitution
Commodore Capital LP3.94%3,000,000$30.72MInstitution

1 of 3

NRIX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
NRIX90.60%9.40%Net SellingNet Selling
SYRE69.85%30.15%Net Selling
OCS8.00%0.00%
AVXL34.70%5.13%Net BuyingNet Buying
PHVS82.10%0.00%
View Top Biotech Stocks

Nurix Therapeutics Stock Ownership FAQ

Who owns Nurix Therapeutics?

Nurix Therapeutics (NASDAQ: NRIX) is owned by 106.37% institutional shareholders, 11.04% Nurix Therapeutics insiders, and 0.00% retail investors. Third Rock Ventures III LP is the largest individual Nurix Therapeutics shareholder, owning 3.51M shares representing 4.60% of the company. Third Rock Ventures III LP's Nurix Therapeutics shares are currently valued at $35.94M.

If you're new to stock investing, here's how to buy Nurix Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.